DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 153 filers reported holding DIPLOMAT PHARMACY INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,377,000 | -18.6% | 1,344,353 | -0.2% | 0.00% | -50.0% |
| Q3 2019 | $6,604,000 | -15.8% | 1,347,592 | +4.7% | 0.00% | 0.0% |
| Q2 2019 | $7,842,000 | +5.8% | 1,287,550 | +0.9% | 0.00% | 0.0% |
| Q1 2019 | $7,413,000 | -57.3% | 1,275,894 | -1.1% | 0.00% | -60.0% |
| Q4 2018 | $17,370,000 | -31.3% | 1,290,490 | -1.0% | 0.01% | -16.7% |
| Q3 2018 | $25,295,000 | -24.0% | 1,303,171 | +0.0% | 0.01% | -25.0% |
| Q2 2018 | $33,296,000 | +34.3% | 1,302,681 | +5.9% | 0.01% | +33.3% |
| Q1 2018 | $24,785,000 | -0.6% | 1,230,011 | -1.0% | 0.01% | 0.0% |
| Q4 2017 | $24,938,000 | -3.5% | 1,242,514 | -0.4% | 0.01% | -14.3% |
| Q3 2017 | $25,845,000 | +41.5% | 1,247,910 | +1.1% | 0.01% | +40.0% |
| Q2 2017 | $18,270,000 | +81.1% | 1,234,477 | +95.1% | 0.01% | +66.7% |
| Q1 2017 | $10,090,000 | +22.9% | 632,643 | -2.9% | 0.00% | 0.0% |
| Q4 2016 | $8,208,000 | -67.0% | 651,344 | -26.7% | 0.00% | -62.5% |
| Q3 2016 | $24,903,000 | -6.9% | 889,059 | +16.3% | 0.01% | -11.1% |
| Q2 2016 | $26,752,000 | +57.6% | 764,372 | +24.5% | 0.01% | +50.0% |
| Q1 2016 | $16,977,000 | -13.7% | 613,763 | +6.8% | 0.01% | -14.3% |
| Q4 2015 | $19,669,000 | +49.3% | 574,824 | +25.3% | 0.01% | +75.0% |
| Q3 2015 | $13,176,000 | +32.6% | 458,629 | +106.5% | 0.00% | +33.3% |
| Q2 2015 | $9,938,000 | +93.8% | 222,092 | +49.8% | 0.00% | +50.0% |
| Q1 2015 | $5,128,000 | +26.6% | 148,286 | +0.2% | 0.00% | +100.0% |
| Q4 2014 | $4,051,000 | – | 148,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|